Direct-to-consumer genomic testing concerns explored

February 18, 2014
Direct-to-consumer genomic testing concerns explored

(HealthDay)—Various concerns relate to direct-to-consumer genomic testing, according to an ideas and opinions piece published online Feb. 10 in the Annals of Internal Medicine.

In August 2013, the company 23andMe launched an advertising campaign to sell its Personal Genome Service (PGS). Michael F. Murray, M.D., from the Geisinger Health System in Danville, Pa., discusses the U.S. Food and Drug Administration warning letter issued to 23andMe to discontinue marketing the PGS until it received FDA approval.

The author explains that 23andMe receives DNA samples in the mail and provides detailed analyses of for consumers, including reports on 254 diseases and conditions. However, these reports are mainly based on genome-wide association studies. For most of the conditions in the reports, there is no evidence that the results of the association studies can be applied as appropriate screening tests. In addition, concerns relating to direct-to-consumer PGS include economic concerns, such as increased for managing patients post-testing, and a concern that overregulation may limit innovation in this arena.

"Physicians should push for the building of patient-centered infrastructure to assist them in delivering valid genome-directed care as it develops," the author writes. "As for 23andMe, it would seem logical for the company to invest in research that determines the actual clinical value of their tests, and they should be expected to meet the same evidence standards as other device manufacturers under FDA jurisdiction."

Explore further: Academics decry FDA crackdown on genome service companies

More information: Full Text (subscription or payment may be required)

Related Stories

Academics decry FDA crackdown on genome service companies

January 16, 2014
(Medical Xpress)—Dr. Robert Green, a medical geneticist with Brigham and Women's Hospital and Nita Farahany, professor of genome sciences and policy at Duke University, who also happens to be a lawyer have stepped into ...

23andMe faces class action lawsuit in California

December 3, 2013
Genetic testing company 23andMe is facing a class action lawsuit alleging that the Silicon Valley startup misled customers about its test kit.

US tells 23andMe to halt sales of genetic test

November 25, 2013
The U.S. Food and Drug Administration is ordering genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science.

It is game over for 23andMe, and rightly so

November 27, 2013
The market for personal genome services is facing a reality check. While the most prominent and innovative company 23andMe has flourished so far, in the past few years many of its competitors have gone out of business. Now, ...

Putting the brakes on home genetic testing: Four questions with geneticist Scott Diehl

December 4, 2013
The Food and Drug Administration recently ordered an end to sales of the home genetic testing kit 23andMe. FDA medical experts said the kit's manufacturers had failed to prove their claim that the $99 test can help customers ...

11 new genetic associations for asthma-with-hay fever

January 28, 2014
23andMe has participated in the first ever genome-wide association study of the combined asthma-with-hay fever phenotype. Led by researchers at the QIMR Berghofer Medical Research Institute, the study identified 11 independent ...

Recommended for you

Epigenetics study helps focus search for autism risk factors

January 16, 2018
Scientists have long tried to pin down the causes of autism spectrum disorder. Recent studies have expanded the search for genetic links from identifying genes toward epigenetics, the study of factors that control gene expression ...

Group recreates DNA of man who died in 1827 despite having no body to work with

January 16, 2018
An international team of researchers led by a group with deCODE Genetics, a biopharmaceutical company in Iceland, has partly recreated the DNA of a man who died in 1827, despite having no body to take tissue samples from. ...

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

The surprising role of gene architecture in cell fate decisions

January 16, 2018
Scientists read the code of life—the genome—as a sequence of letters, but now researchers have also started exploring its three-dimensional organisation. In a paper published in Nature Genetics, an interdisciplinary research ...

How incurable mitochondrial diseases strike previously unaffected families

January 15, 2018
Researchers have shown for the first time how children can inherit a severe - potentially fatal - mitochondrial disease from a healthy mother. The study, led by researchers from the MRC Mitochondrial Biology Unit at the University ...

Genes that aid spinal cord healing in lamprey also present in humans

January 15, 2018
Many of the genes involved in natural repair of the injured spinal cord of the lamprey are also active in the repair of the peripheral nervous system in mammals, according to a study by a collaborative group of scientists ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.